KIT D816V Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| (PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation (NCT04811365) | Blueprint Medicines Corporation | 2021-06-29 |
Track KIT D816V Mutation automatically
Every clearance here is in the API, with alerts when new ones post.